Changes in Sexual Activity and Function After Pelvic Organ Prolapse Surgery: A Systematic Review.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
11 2020
Historique:
pubmed: 9 10 2020
medline: 1 12 2020
entrez: 8 10 2020
Statut: ppublish

Résumé

We aimed to systematically review the literature to describe sexual activity and function before and after prolapse surgery. We searched MEDLINE, EMBASE, and ClinicalTrials.gov databases from inception to April 2018. Prospective, comparative studies of reconstructive pelvic organ prolapse (POP) surgeries that reported sexual function outcomes were included. Studies were extracted for population characteristics, sexual function outcomes, and methodologic quality. Data collected included baseline and postoperative sexual activity, dyspareunia, and validated sexual function questionnaire scores. Change in validated scores were used to categorize overall sexual function as improved, unchanged, or worsened after surgery. The search revealed 3,124 abstracts and identified 74 articles representing 67 original studies. The overall quality of evidence was moderate to high. Studies reporting postoperative results found higher rates of sexual activity than studies reporting preoperative sexual activity in all POP surgeries except sacrospinous suspension, transvaginal mesh, and sacrocolpopexy. The prevalence of dyspareunia decreased after all prolapse surgery types. The risk of de novo dyspareunia ranged from 0% to 9% for all POP surgeries except posterior repair, which lacked sufficient data. Overall sexual function based on PISQ-12 (Pelvic Organ Prolapse/Incontinence Sexual Questionnaire-12) scores improved for mixed native tissue repairs, anterior repairs, uterosacral suspensions, sacrospinous suspensions, and sacrocolpopexy; scores were similar for posterior repairs, transvaginal mesh, and biologic grafts. Sexual function did not worsen after any POP surgeries. Sexual function improves or remains unchanged after all types of reconstructive POP surgeries and does not worsen for any surgery type. Prevalence of total dyspareunia was lower after all POP surgery types, and de novo dyspareunia was low ranging 0-9%. This information can help surgeons counsel patients preoperatively. PROSPERO, CRD42019124308.

Identifiants

pubmed: 33030874
doi: 10.1097/AOG.0000000000004125
pii: 00006250-202011000-00010
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

922-931

Références

Wu JM, Matthews CA, Conover MM, Pate V, Jonsson Funk M. Lifetime risk of stress urinary incontinence or pelvic organ prolapse surgery. Obstet Gynecol 2014;123:1201–6.
Sung VW, Rogers RG, Barber MD, Clark MA. Conceptual framework for patient-important treatment outcomes for pelvic organ prolapse. Neurourol Urodyn 2014;33:414–9.
Dunivan GC, Sussman AL, Jelovsek JE, Sung V, Andy UU, Ballard A, et al. Gaining the patient perspective on pelvic floor disorders' surgical adverse events. Am J Obstet Gynecol 2019;220:185.e1–10.
Pauls RN, Segal JL, Silva WA, Kleeman SD, Karram MM. Sexual function in patients presenting to a urogynecology practice. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:576–80.
Dietz V, Maher C. Pelvic organ prolapse and sexual function. Int Urogynecol J 2013;24:1853–7.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919.
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol 2014;14:135.
Berkman ND, Lohr KN, Ansari MT, Balk EM, Kane R, McDonagh M, et al. Grading the strength of a body of evidence when assessing health care interventions: an EPC update. J Clin Epidemiol 2015;68:1312–24.
Jha S, Gray T. A systematic review and meta-analysis of the impact of native tissue repair for pelvic organ prolapse on sexual function. Int Urogynecol J 2015;26:321–7.
Damiani GR, Riva D, Pellegrino A, Gaetani M, Tafuri S, Turoli D, et al. Conventional fascial technique versus mesh repair for advanced pelvic organ prolapse: analysis of recurrences in treated and untreated compartments. J Obstet Gynaecol 2016;36:410–5.
Sokol AI, Iglesia CB, Kudish BI, Gutman RE, Shveiky D, Bercik R, et al. One-year objective and functional outcomes of a randomized clinical trial of vaginal mesh for prolapse. Am J Obstet Gynecol 2012;206:86–9.
Gutman RE, Nosti PA, Sokol AI, Sokol ER, Peterson JL, Wang H, et al. Three-year outcomes of vaginal mesh for prolapse: a randomized controlled trial. Obstet Gynecol 2013;122:770–7.
Carey M, Higgs P, Goh J, Lim J, Leong A, Krause H, et al. Vaginal repair with mesh versus colporrhaphy for prolapse: a randomised controlled trial. BJOG 2009;116:1380–6.
Withagen MI, Milani AL, den Boon J, Vervest HA, Vierhout ME. Trocar-guided mesh compared with conventional vaginal repair in recurrent prolapse: a randomized controlled trial. Obstet Gynecol 2011;117:242–50.
Lukacz ES, Warren LK, Richter HE, Brubaker L, Barber MD, Norton P, et al. Quality of life and sexual function 2 years after vaginal surgery for prolapse. Obstet Gynecol 2016;127:1071–9.
Dahlgren E, Kjølhede P; Group R-PS. Long-term outcome of porcine skin graft in surgical treatment of recurrent pelvic organ prolapse. An open randomized controlled multicenter study. Acta Obstet Gynecol Scand 2011;90:1393–401.
Madhuvrata P, Glazener C, Boachie C, Allahdin S, Bain C. A randomised controlled trial evaluating the use of polyglactin (Vicryl) mesh, polydioxanone (PDS) or polyglactin (Vicryl) sutures for pelvic organ prolapse surgery: outcomes at 2 years. J Obstet Gynaecol 2011;31:429–35.
Dos Reis Brandao da Silveira S, Haddad JM, de Jármy-Di Bella ZI, Nastri F, Kawabata MG, da Silva Carramão S, et al. Multicenter, randomized trial comparing native vaginal tissue repair and synthetic mesh repair for genital prolapse surgical treatment. Int Urogynecol J 2015;26:335–42.
Glazener C, Breeman S, Elders A, Hemming C, Cooper K, Freeman R, et al. Clinical effectiveness and cost-effectiveness of surgical options for the management of anterior and/or posterior vaginal wall prolapse: two randomised controlled trials within a comprehensive cohort study - results from the PROSPECT Study. Health Technol Assess 2016;20:1–452.
Milani AL, Withagen MI, The HS, Nedelcu-van der Wijk I, Vierhout ME. Sexual function following trocar-guided mesh or vaginal native tissue repair in recurrent prolapse: a randomized controlled trial. J Sex Med 2011;8:2944–53.
Milani AL, Damoiseaux A, IntHout J, Kluivers KB, Withagen MIJ. Long-term outcome of vaginal mesh or native tissue in recurrent prolapse: a randomized controlled trial. Int Urogynecol J 2018;29:847–58.
Dua A, Jha S, Farkas A, Radley S. The effect of prolapse repair on sexual function in women. J Sex Med 2012;9:1459–65.
Siddiqui NY, Fulton RG, Kuchibhatla M, Wu JM. Sexual function after vaginal versus nonvaginal prolapse surgery. Female Pelvic Med Reconstr Surg 2012;18:239–42.
Ignjatovic I, Stojkovic I, Basic D, Medojevic N, Potic M, et al. Optimal primary minimally invasive treatment for patients with stress urinary incontinence and symptomatic pelvic organ prolapse: tension free slings with colporrhaphy, or Prolift with the tension free midurethral sling? Eur J Obstet Gynecol Reprod Biol 2010;150:97–101.
Altman D, Väyrynen T, Engh ME, Axelsen S, Falconer C. Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med 2011;364:1826–36.
Guerette NL, Peterson TV, Aguirre OA, Vandrie DM, Biller DH, Davila GW. Anterior repair with or without collagen matrix reinforcement: a randomized controlled trial. Obstet Gynecol 2009;114:59–65.
Lamblin G, Van-Nieuwenhuyse A, Chabert P, Lebail-Carval K, Moret S, Mellier G. A randomized controlled trial comparing anatomical and functional outcome between vaginal colposuspension and transvaginal mesh. Int Urogynecol J 2014;25:961–70.
Rudnicki M, Laurikainen E, Pogosean R, Kinne I, Jakobsson U, Teleman P. Anterior colporrhaphy compared with collagen-coated transvaginal mesh for anterior vaginal wall prolapse: a randomised controlled trial. BJOG 2014;121:102–10.
Rudnicki M, Laurikainen E, Pogosean R, Kinne I, Jakobsson U, Teleman P. A 3-year follow-up after anterior colporrhaphy compared with collagen-coated transvaginal mesh for anterior vaginal wall prolapse: a randomised controlled trial. BJOG 2016;123:136–42.
Sivaslioglu AA, Unlubilgin E, Dolen I. A randomized comparison of polypropylene mesh surgery with site-specific surgery in the treatment of cystocoele. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:467–71.
de Tayrac R, Cornille A, Eglin G, Guilbaud O, Mansoor A, Alonso S, et al. Comparison between trans-obturator trans-vaginal mesh and traditional anterior colporrhaphy in the treatment of anterior vaginal wall prolapse: results of a French RCT. Int Urogynecol J 2013;24:1651–61.
Feldner PC Jr, Castro RA, Cipolotti LA, Delroy CA, Sartori MG, Girão MJ. Anterior vaginal wall prolapse: a randomized controlled trial of SIS graft versus traditional colporrhaphy. Int Urogynecol J 2010;21:1057–63.
Feldner PC Jr, Delroy CA, Martins SB, Castro RA, Sartori MGF, Girão MJBC. Sexual function after anterior vaginal wall prolapse surgery. Clinics (Sao Paulo) 2012;67:871–5.
Tantanasis T, Giannoulis C, Daniilidis A, Papathanasiou K, Loufopoulos A, Tzafettas J. Anterior vaginal wall reconstruction: anterior colporrhaphy reinforced with tension free vaginal tape underneath bladder base. Acta Obstet Gynecol Scand 2008;87:464–8.
Nieminen K, Hiltunen R, Heiskanen E, Takala T, Niemi K, Merikari M, et al. Symptom resolution and sexual function after anterior vaginal wall repair with or without polypropylene mesh. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:1611–6.
Nieminen K, Hiltunen R, Takala T, Heiskanen E, Merikari M, Niemi K, et al. Outcomes after anterior vaginal wall repair with mesh: a randomized, controlled trial with a 3 year follow-up. Am J Obstet Gynecol 2010;203:235–8.
Vollebregt A, Fischer K, Gietelink D, van der Vaart CH. Primary surgical repair of anterior vaginal prolapse: a randomised trial comparing anatomical and functional outcome between anterior colporrhaphy and trocar-guided transobturator anterior mesh. BJOG 2011;118:1518–27.
Vollebregt A, Fischer K, Gietelink D, van der Vaart CH. Effects of vaginal prolapse surgery on sexuality in women and men; results from a RCT on repair with and without mesh. J Sex Med 2012;9:1200–11.
Nguyen JN, Burchette RJ. Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol 2008;111:891–8.
Komesu YM, Rogers RG, Kammerer-Doak DN, Barber MD, Olsen AL. Posterior repair and sexual function. Am J Obstet Gynecol 2007;197:101–6.
Sung VW, Rardin CR, Raker CA, Lasala CA, Myers DL. Porcine subintestinal submucosal graft augmentation for rectocele repair: a randomized controlled trial. Obstet Gynecol 2012;119:125–33.
Madsen LD, Nüssler E, Kesmodel US, Greisen S, Bek KM, Glavind-Kristensen M. Native-tissue repair of isolated primary rectocele compared with nonabsorbable mesh: patient-reported outcomes. Int Urogynecol J 2017;28:49–57.
Farid M, Madbouly KM, Hussein A, Mahdy T, Moneim HA, Omar W. Randomized controlled trial between perineal and anal repairs of rectocele in obstructed defecation. World J Surg 2010;34:822–9.
Paraiso MF, Barber MD, Muir TW, Walters MD. Rectocele repair: a randomized trial of three surgical techniques including graft augmentation. Am J Obstet Gynecol 2006;195:1762–71.
Novi JM, Bradley CS, Mahmoud NN, Morgan MA, Arya LA. Sexual function in women after rectocele repair with acellular porcine dermis graft vs site-specific rectovaginal fascia repair. Int Urogynecol J Pelvic Floor Dysfunct 2007;18:1163–9.
Nieminen K, Hiltunen KM, Laitinen J, Oksala J, Heinonen PK. Transanal or vaginal approach to rectocele repair: a prospective, randomized pilot study. Dis Colon Rectum 2004;47:1636–42.
Fayyad AM, Redhead E, Awan N, Kyrgiou M, Prashar S, Hill SR. Symptomatic and quality of life outcomes after site-specific fascial reattachment for pelvic organ prolapse repair. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:191–7.
Balci O, Capar M, Acar A, Colakoglu MC. Balci technique for suspending vaginal vault at vaginal hysterectomy with reduced risk of vaginal vault prolapse. J Obstet Gynaecol Res 2011;37:762–9.
Uçar MG, İlhan TT, Şanlikan F, Çelik Ç. Sexual functioning before and after vaginal hysterectomy to treat pelvic organ prolapse and the effects of vaginal cuff closure techniques: a prospective randomised study. Eur J Obstet Gynecol Reprod Biol 2016;206:1–5.
Rondini C, Braun H, Alvarez J, Urzúa MJ, Villegas R, Wenzel C, et al. High uterosacral vault suspension vs sacrocolpopexy for treating apical defects: a randomized controlled trial with twelve months follow-up. Int Urogynecol J 2015;26:1131–8.
Kokanali MK, Cavkaytar S, Aksakal O, Doğanay M. McCall Culdoplasty vs. sacrospinous ligament fixation after vaginal hysterectomy: comparison of postoperative vaginal length and sexual function in postmenopausal women. Eur J Obstet Gynecol Reprod Biol 2015;194:218–22.
Svabik K, Martan A, Masata J, El-Haddad R, Hubka P. Comparison of vaginal mesh repair with sacrospinous vaginal colpopexy in the management of vaginal vault prolapse after hysterectomy in patients with levator ani avulsion: a randomized controlled trial. Ultrasound Obstet Gynecol 2014;43:365–71.
Halaska M, Maxova K, Sottner O, Svabik K, Mlcoch M, Kolarik D, et al. A multicenter, randomized, prospective, controlled study comparing sacrospinous fixation and transvaginal mesh in the treatment of posthysterectomy vaginal vault prolapse. Am J Obstet Gynecol 2012;207:301–7.
Maher CF, Qatawneh AM, Dwyer PL, Carey MP, Cornish A, Schluter PJ. Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal vault prolapse: a prospective randomized study. Am J Obstet Gynecol 2004;190:20–6.
de Tayrac R, Mathé ML, Bader G, Deffieux X, Fazel A, Fernandez H. Infracoccygeal sacropexy or sacrospinous suspension for uterine or vaginal vault prolapse. Int J Gynaecol Obstet 2008;100:154–9.
Kraus P, Krofta L, Krčmář M, Urbánková I, Gojiš O. The results of five years follow-up prospective study of vaginal prolapse repaired by Prolift total mesh surgery or sacrospinous fixation [in Czech]. Ceska Gynekol;82:277–86.
Heinonen PK, Nieminen K. Combined anterior vaginal wall mesh with sacrospinous ligament fixation or with posterior intravaginal slingplasty for uterovaginal or vaginal vault prolapse. Eur J Obstet Gynecol Reprod Biol 2011;157:230–3.
Detollenaere RJ, Kreuwel IA, Dijkstra JR, Kluivers KB, van Eijndhoven HW. The impact of sacrospinous hysteropexy and vaginal hysterectomy with suspension of the uterosacral ligaments on sexual function in women with uterine prolapse: a secondary analysis of a randomized comparative study. J Sex Med 2016;13:213–9.
Jeng CJ, Yang YC, Tzeng CR, Shen J, Wang LR. Sexual functioning after vaginal hysterectomy or transvaginal sacrospinous uterine suspension for uterine prolapse: a comparison. J Reprod Med 2005;50:669–74.
Eftekhar TF, Alizadeh S, Shabihkhani S, Hajhashemy M. Apical prolapse surgical treatment outcomes: transabdominal versus transvaginal approach. J Gynecol Surg 2018;34:68–73.
Lo TSW, Wang AC. Abdominal colposacropexy and sacrospinous ligament suspension for severe uterovaginal prolapse: a comparison. J Gynecol Surg 2009;14:59–64.
Detollenaere RJ, den Boon J, Stekelenburg J, IntHout J, Vierhout ME, Kluivers KB, et al. Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial. BMJ 2015;351:h3717.
Feiner B, O'Rourke P, Maher C. A prospective comparison of two commercial mesh kits in the management of anterior vaginal prolapse. Int Urogynecol J 2012;23:279–83.
Maher CF, Feiner B, DeCuyper EM, Nichlos CJ, Hickey KV, O'Rourke P. Laparoscopic sacral colpopexy versus total vaginal mesh for vaginal vault prolapse: a randomized trial. Am J Obstet Gynecol 2011;204:360–7.
Natale F, La Penna C, Padoa A, Agostini M, De Simone E, Cervigni M. A prospective, randomized, controlled study comparing Gynemesh, a synthetic mesh, and Pelvicol, a biologic graft, in the surgical treatment of recurrent cystocele. Int Urogynecol J Pelvic Floor Dysfunct 2009;20:75–81.
Yuk JS, Jin CH, Yi KW, Kim T, Hur JY, Shin JH. Anterior transobturator polypropylene mesh in the correction of cystocele: 2-point method vs 4-point method. J Minim Invasive Gynecol 2012;19:737–41.
Lucot JP, Cosson M, Bader G, Debodinance P, Akladios C, Salet-Lizée D, et al. Safety of vaginal mesh surgery versus laparoscopic mesh sacropexy for cystocele repair: results of the prosthetic pelvic floor repair randomized controlled trial. Eur Urol 2018;74:167–76.
Gutman RE, Rardin CR, Sokol ER, Matthews C, Park AJ, Iglesia CB, et al. Vaginal and laparoscopic mesh hysteropexy for uterovaginal prolapse: a parallel cohort study. Am J Obstet Gynecol 2017;216:38.e1–11.
Liang CC, Lo TS, Tseng LH, Lin YH, Lin YJ, Chang SD. Sexual function in women following transvaginal mesh procedures for the treatment of pelvic organ prolapse. Int Urogynecol J 2012;23:1455–60.
Gupta P, Payne J, Killinger KA, Ehlert M, Bartley J, Gilleran J, et al. Analysis of changes in sexual function in women undergoing pelvic organ prolapse repair with abdominal or vaginal approaches. Int Urogynecol J 2016;27:1919–24.
Zucchi A, Costantini E, Mearini L, Fioretti F, Bini V, Porena M. Female sexual dysfunction in urogenital prolapse surgery: colposacropexy vs. hysterocolposacropexy. J Sex Med 2008;5:139–45.
Deprest J, De Ridder D, Roovers JP, Werbrouck E, Coremans G, Claerhout F. Medium term outcome of laparoscopic sacrocolpopexy with xenografts compared to synthetic grafts. J Urol 2009;182:2362–8.
Kenton K, Mueller ER, Tarney C, Bresee C, Anger JT. One-year outcomes after minimally invasive sacrocolpopexy. Female Pelvic Med Reconstr Surg 2016;22:382–4.
Culligan PJ, Salamon C, Priestley JL, Shariati A. Porcine dermis compared with polypropylene mesh for laparoscopic sacrocolpopexy: a randomized controlled trial. Obstet Gynecol 2013;121:143–51.
Salamon CG, Lewis CM, Priestley J, Culligan PJ. Sexual function before and 1 year after laparoscopic sacrocolpopexy. Female Pelvic Med Reconstr Surg 2014;20:44–7.
Li S, Ji M, Zhao Z. The effectiveness of two different laparoscopic surgeries for apical support of pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol 2015;188:74–8.
Costantini E, Mearini L, Bini V, Zucchi A, Mearini E, Porena M. Uterus preservation in surgical correction of urogenital prolapse. Eur Urol 2005;48:642–9.
Paraiso MF, Jelovsek JE, Frick A, Chen CC, Barber MD. Laparoscopic compared with robotic sacrocolpopexy for vaginal prolapse: a randomized controlled trial. Obstet Gynecol 2011;118:1005–13.
Brubaker L, Nygaard I, Richter HE, Visco A, Weber AM, Cundiff GW, et al. Two-year outcomes after sacrocolpopexy with and without Burch to prevent stress urinary incontinence. Obstet Gynecol 2008;112:49–55.
Handa VL, Zyczynski HM, Brubaker L, Nygaard I, Janz NK, Richter HE, et al. Sexual function before and after sacrocolpopexy for pelvic organ prolapse. Am J Obstet Gynecol 2007;197:629–6.
U.S. Food and Drug Administration. Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. Available at: https://www.fda.gov/media/81123/download. Retrieved July 19, 2019.

Auteurs

Danielle D Antosh (DD)

Departments of Obstetrics and Gynecology, Houston Methodist Hospital, Houston, Texas, the University of Calgary, Calgary, Alberta, Canada, the University of New Mexico, Albuquerque, New Mexico, Salinas Valley Memorial Healthcare System, Salinas, California, the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, Albert Einstein College of Medicine, Bronx, New York, the University of Florida, Jacksonville, Florida, UT Health, San Antonio, Texas, HCA/UCF Consortium, Gainesville, Florida, UT Southwestern Medical Center, Dallas, Texas, and Albany Medical Center, Albany, New York; the Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, Rhode Island; and the Department of Women's Health, University of Texas at Austin Dell Medical School, Austin, Texas.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH